Iron oxide-transfection agent complexes are not expected to coat the cell membrane and prevent CD71 expression.
Janic
Branislava
B
Arbab
Ali S
AS
D000818:Animals; D003287:Contrast Media / Q000493:pharmacokinetics*; D003911:Dextrans; D052203:Ferrosoferric Oxide; D005434:Flow Cytometry; D015870:Gene Expression / Q000187:drug effects; D007501:Iron / Q000493:pharmacokinetics*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058185:Magnetite Nanoparticles; D008297:Male; D059630:Mesenchymal Stem Cells; D010087:Oxides / Q000493:pharmacokinetics*; D010316:Particle Size; D051381:Rats; D017207:Rats, Sprague-Dawley; D011990:Receptors, Transferrin / Q000378:metabolism*; D014162:Transfection; D015854:Up-Regulation
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; D011990:Receptors, Transferrin; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide